AgingResearch.News
AHA Scientific Sessions 2025 Abstract

Low-Dose GLP-1 Receptor Agonist Therapy Exerts Anti-Fibrotic Effects Across Multiple Organs in Cardiometabolic HFpEF

By Mahmoud H. Elbatreek, Natalie Gehred, Tatiana Gromova, Show 9 more authorsDavid J. Lefer
Experiments in animalsInterventions
Paper

The paper

Mahmoud H. Elbatreek, Natalie Gehred, Tatiana Gromova, Show 9 more authorsDavid J. Lefer

Cedars-Sinai Medical Center

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4359422

doi.org/10.1161/circ.152.suppl_3.4359422

Related